Annual Non Current Assets
$139.59 M
-$67.58 M-32.62%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual long term assets is $139.59 million, with the most recent change of -$67.58 million (-32.62%) on December 31, 2023.
- During the last 3 years, RVNC annual non current assets has fallen by -$130.63 million (-48.34%).
- RVNC annual non current assets is now -51.03% below its all-time high of $285.05 million, reached on December 31, 2021.
Performance
RVNC Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$131.88 M
-$12.75 M-8.82%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly long term assets is $131.88 million, with the most recent change of -$12.75 million (-8.82%) on September 30, 2024.
- Over the past year, RVNC quarterly non current assets has dropped by -$12.09 million (-8.40%).
- RVNC quarterly non current assets is now -62.77% below its all-time high of $354.22 million, reached on March 31, 2022.
Performance
RVNC Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
RVNC Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.6% | -8.4% |
| 3 y3 years | -48.3% | -54.2% |
| 5 y5 years | +657.6% | +191.5% |
RVNC Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.0% | at low | -62.8% | at low |
| 5 y | 5-year | -51.0% | +219.5% | -62.8% | +201.9% |
| alltime | all time | -51.0% | +1641.0% | -62.8% | +1544.8% |
Revance Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $131.88 M(-8.8%) |
| Jun 2024 | - | $144.63 M(+4.5%) |
| Mar 2024 | - | $138.43 M(-0.8%) |
| Dec 2023 | $338.87 M(-9.6%) | $139.59 M(-3.0%) |
| Sep 2023 | - | $143.97 M(-34.1%) |
| Jun 2023 | - | $218.59 M(-2.8%) |
| Mar 2023 | - | $224.78 M(+8.5%) |
| Dec 2022 | $374.73 M(+52.3%) | $207.17 M(-30.0%) |
| Sep 2022 | - | $296.00 M(-1.6%) |
| Jun 2022 | - | $300.94 M(-15.0%) |
| Mar 2022 | - | $354.22 M(+24.3%) |
| Dec 2021 | $246.12 M(-45.3%) | $285.05 M(-1.0%) |
| Sep 2021 | - | $287.94 M(+0.6%) |
| Jun 2021 | - | $286.27 M(+6.2%) |
| Mar 2021 | - | $269.52 M(-0.3%) |
| Dec 2020 | $450.00 M(+51.7%) | $270.22 M(+3.1%) |
| Sep 2020 | - | $262.04 M(+257.0%) |
| Jun 2020 | - | $73.41 M(-1.4%) |
| Mar 2020 | - | $74.49 M(+70.5%) |
| Dec 2019 | $296.60 M(+42.7%) | $43.69 M(-3.4%) |
| Sep 2019 | - | $45.24 M(-1.6%) |
| Jun 2019 | - | $45.99 M(-2.9%) |
| Mar 2019 | - | $47.36 M(+157.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $207.92 M(-27.1%) | $18.43 M(+7.3%) |
| Sep 2018 | - | $17.17 M(+5.7%) |
| Jun 2018 | - | $16.24 M(+42.9%) |
| Mar 2018 | - | $11.36 M(+8.3%) |
| Dec 2017 | $285.21 M(+48.0%) | $10.49 M(-18.8%) |
| Sep 2017 | - | $12.92 M(+1.5%) |
| Jun 2017 | - | $12.72 M(+6.0%) |
| Mar 2017 | - | $12.00 M(+2.9%) |
| Dec 2016 | $192.69 M(-24.1%) | $11.66 M(-35.8%) |
| Sep 2016 | - | $18.18 M(-1.5%) |
| Jun 2016 | - | $18.45 M(-10.0%) |
| Mar 2016 | - | $20.51 M(-6.2%) |
| Dec 2015 | $253.96 M(+47.0%) | $21.86 M(-0.7%) |
| Sep 2015 | - | $22.02 M(-35.2%) |
| Jun 2015 | - | $33.96 M(+69.5%) |
| Mar 2015 | - | $20.03 M(+1.5%) |
| Dec 2014 | $172.73 M(+3488.1%) | $19.74 M(+9.6%) |
| Sep 2014 | - | $18.01 M(+7.5%) |
| Jun 2014 | - | $16.76 M(+6.5%) |
| Mar 2014 | - | $15.74 M(-11.7%) |
| Dec 2013 | $4.81 M(-10.9%) | $17.83 M(+12.2%) |
| Sep 2013 | - | $15.89 M(+98.2%) |
| Dec 2012 | $5.41 M(-82.1%) | $8.02 M |
| Dec 2011 | $30.12 M | - |
FAQ
- What is Revance Therapeutics annual long term assets?
- What is the all time high annual non current assets for Revance Therapeutics?
- What is Revance Therapeutics annual non current assets year-on-year change?
- What is Revance Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Revance Therapeutics?
- What is Revance Therapeutics quarterly non current assets year-on-year change?
What is Revance Therapeutics annual long term assets?
The current annual non current assets of RVNC is $139.59 M
What is the all time high annual non current assets for Revance Therapeutics?
Revance Therapeutics all-time high annual long term assets is $285.05 M
What is Revance Therapeutics annual non current assets year-on-year change?
Over the past year, RVNC annual long term assets has changed by -$67.58 M (-32.62%)
What is Revance Therapeutics quarterly long term assets?
The current quarterly non current assets of RVNC is $131.88 M
What is the all time high quarterly non current assets for Revance Therapeutics?
Revance Therapeutics all-time high quarterly long term assets is $354.22 M
What is Revance Therapeutics quarterly non current assets year-on-year change?
Over the past year, RVNC quarterly long term assets has changed by -$12.09 M (-8.40%)